Annual Drug Patent Expirations for ERIVEDGE
Erivedge is a drug marketed by Genentech and is included in one NDA. It is available from one supplier. There are two patents protecting this drug.
This drug has forty-seven patent family members in twenty-four countries.
The generic ingredient in ERIVEDGE is vismodegib. One supplier is listed for this compound. Additional details are available on the vismodegib profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com